Stock Trading History of Bentsur Ron
The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider
Bentsur Ron since year 2005.
The trader's CIK number is
1251213.
At the time of this reporting, Bentsur Ron is the CEO of
Xtl Biopharmaceuticals Ltd
(stock ticker symbol
XTLB).
Note that in the past
BENTSUR RON also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by Bentsur Ron since 2005.
| Trade Date |
Symbol |
Company Name (Issuer) |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-08-21 | XTLB | Xtl Biopharmaceuticals Ltd | Purchase | 15,279 | 1.30 | 19,862 |
| 2006-08-25 | XTLB | Xtl Biopharmaceuticals Ltd | Purchase | 1,600 | 2.98 | 4,768 |
| 2006-03-29 | KERX | Keryx Biopharmaceuticals Inc | Sale | 35,000 | 18.84 | 659,276 |
| 2006-03-29 | KERX | Keryx Biopharmaceuticals Inc | Option Exercise | 35,000 | 1.10 | 38,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bentsur Ron
(CEO of Xtl Biopharmaceuticals Ltd at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
